Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Lynparza Approved in Japan for BRCA-Mutated Metastatic Breast Cancer

americanpharmaceuticalreviewJuly 11, 2018

Tag: Lynparza , BRCA-Mutated , Japan

PharmaSources Customer Service